v3.26.1
SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2026
Segment Reporting [Line Items]      
Revenues $ 1,768 $ 1,760  
Cost of revenues (1,543) (1,604)  
Research and development (1,959) (3,086)  
Selling, general, and administrative (4,878) (4,687)  
Loss from operations (6,612) (7,617)  
Interest and finance expense (1,492) (548)  
Net loss before income taxes (7,935) (7,691)  
Depreciation and amortization 800 800  
Stock-based compensation expense 1,036 1,577  
Cash used in operations (4,946) (4,526)  
Cash from investing 461 576  
Cash from financing 3,058 4,066  
Impact of exchange rates (21) 127  
Net change for the period (1,448) 243  
Cash, cash equivalents and marketable securities 15,217   $ 17,263
TOTAL ASSETS 32,891   35,385
Total liabilities (30,052)   (29,175)
Non-controlling interest 842   84
Business Segment [Member] | Variable Interest Entities [Member] | Parent Company [Member]      
Segment Reporting [Line Items]      
Capital expenditures 208 198  
Revenues 1,768 1,760  
Cost of revenues 1,543 1,604  
Research and development 1,959 3,086  
Selling, general, and administrative 4,878 4,687  
Loss from operations (6,612) (7,617)  
Interest and finance expense (1,492) (548)  
Other non-operating income/(expense) (50) 87  
Net loss before income taxes (8,154) (8,078)  
Depreciation and amortization 797 805  
Stock-based compensation expense 1,036 1,577  
Cash used in operations (4,946) (4,526)  
Cash from investing 461 576  
Cash from financing 3,058 4,066  
Impact of exchange rates (21) 127  
Net change for the period (1,448) 243  
Cash, cash equivalents and marketable securities 9,812   11,641
All other assets 23,079   23,744
TOTAL ASSETS 32,891   35,385
Total liabilities (30,052)   (29,175)
Net assets 2,839   6,210
Non-controlling interest 842   84
Beyond Air [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures 206 198  
Revenues 1,768 1,760  
Cost of revenues 1,543 1,604  
Research and development 1,747 2,234  
Selling, general, and administrative 3,663 3,328  
Loss from operations (5,185) (5,406)  
Interest and finance expense (1,492) (548)  
Other non-operating income/(expense) (101) 110  
Net loss before income taxes (6,778) (5,844)  
Depreciation and amortization 796 795  
Stock-based compensation expense 332 1,000  
Cash used in operations (4,355) (3,755)  
Cash from investing 327 215  
Cash from financing (170) 4,066  
Impact of exchange rates (10) 148  
Net change for the period (4,208) 674  
Cash, cash equivalents and marketable securities 5,688   10,140
All other assets 23,310   23,901
TOTAL ASSETS 28,998   34,041
Total liabilities (29,097)   (28,224)
Net assets (99)   5,817
Non-controlling interest  
Beyond Cancer Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures  
Revenues  
Cost of revenues  
Research and development 54 529  
Selling, general, and administrative 189 952  
Loss from operations (243) (1,481)  
Interest and finance expense  
Other non-operating income/(expense) 41 (25)  
Net loss before income taxes (202) (1,506)  
Depreciation and amortization 1 10  
Stock-based compensation expense 66 512  
Cash used in operations (169) (439)  
Cash from investing 136 361  
Cash from financing  
Impact of exchange rates (60) 31  
Net change for the period (93) (47)  
Cash, cash equivalents and marketable securities 813   1,043
All other assets (273)   (219)
TOTAL ASSETS 540   824
Total liabilities (292)   (378)
Net assets 248   446
Non-controlling interest 35   64
NeuroNos Ltd [Member] | Business Segment [Member] | Variable Interest Entities [Member]      
Segment Reporting [Line Items]      
Capital expenditures 2  
Revenues  
Cost of revenues  
Research and development 158 323  
Selling, general, and administrative 1,026 407  
Loss from operations (1,184) (730)  
Interest and finance expense  
Other non-operating income/(expense) 10 2  
Net loss before income taxes (1,174) (728)  
Depreciation and amortization  
Stock-based compensation expense 638 65  
Cash used in operations (422) (332)  
Cash from investing (2)  
Cash from financing 3,228  
Impact of exchange rates 49 (52)  
Net change for the period 2,853 $ (384)  
Cash, cash equivalents and marketable securities 3,311   458
All other assets 42   62
TOTAL ASSETS 3,353   520
Total liabilities (663)   (573)
Net assets 2,690   (53)
Non-controlling interest $ 807   $ 20